Related Experiment Video
Updated: Jun 8, 2026

02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Penile traction therapy in Peyronie's disease
1Department of Urology, Columbia University Medical Center The Herbert Irving Pavilion, 161 Fort Washington Avenue, 11th Floor, New York, NY 10032 USA.
F1000 Medicine Reports
|October 16, 2010
Summary
Penile traction therapy is being studied for Peyronie
Area of Science:
- Urology
- Andrology
- Regenerative Medicine
Background:
- Penile traction therapy (PTT) traditionally aims to increase penile length.
- Emerging research explores PTT for Peyronie's disease curvature.
- Peyronie's disease affects penile health and sexual function.
Purpose of the Study:
- To evaluate the efficacy of penile traction therapy in reducing Peyronie's disease curvature.
- To investigate PTT as a monotherapy for Peyronie's disease.
- To assess PTT in combination with other treatment modalities for Peyronie's disease.
Main Methods:
- Review of existing studies on penile traction therapy for Peyronie's disease.
- Analysis of clinical outcomes related to penile curvature reduction.
- Comparison of PTT as monotherapy versus combination therapy.
Main Results:
- Initial investigations on PTT for Peyronie's disease have yielded conflicting results.
- The true benefit of PTT in reducing penile curvature requires further confirmation.
- Evidence regarding PTT's effectiveness is still developing.
Conclusions:
- Penile traction therapy shows potential but requires more research for Peyronie's disease.
- Further studies are needed to establish PTT's role in managing penile curvature.
- The optimal application of PTT, alone or combined, remains under investigation.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
